Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 3.47 is 79% below its 5-year average of 16.80, near the low end of its 5-year range (2.97–34.48).
As of the fiscal period ended Tuesday, June 30, 2026. 8.18% below its 12-month average of 3.78.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.47.
CURRENT RATIO
3.47
CURRENT RATIO AVG TTM
3.78
CURRENT RATIO AVG 3Y
9.01
CURRENT RATIO AVG 5Y
16.80
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-8.18%
CURRENT VS 3Y AVG
-61.50%
CURRENT VS 5Y AVG
-79.34%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.54
median of 730 covered companies
CURRENT VS SECTOR MEDIAN
-2.11%
vs the sector median at left
Market Cap
$18.54M
Current Ratio
27.85
TTM Avg
15.71
3Y Avg
9.25
5Y Avg
10.43
Market Cap
$20.09M
Current Ratio
1.25
TTM Avg
1.72
3Y Avg
2.15
5Y Avg
2.15
Market Cap
$18.40M
Current Ratio
0.20
TTM Avg
0.34
3Y Avg
6.34
5Y Avg
6.11
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NextCure, Inc. (NXTC) | $19.14M | 3.47 | 3.78 | 9.01 | 16.80 |
| P3 Health Partners Inc. (PIII)vs › | $19.66M | 0.46 | 0.30 | 0.39 | 0.60 |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.54M | 27.85 | 15.71 | 9.25 | 10.43 |
| Actuate Therapeutics Inc (ACTU)vs › | $20.09M | 1.25 | 1.72 | 2.15 | 2.15 |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.40M | 0.20 | 0.34 | 6.34 | 6.11 |
| Cosmos Health Inc. (COSM)vs › | $17.36M | 1.05 | 0.99 | 1.52 | 1.43 |
| Quantum BioPharma Ltd. (QNTM)vs › | $20.73M | 1.20 | 1.44 | 1.90 | 2.95 |
| PAVmed Inc. (PAVM)vs › | $17.36M | 1.19 | 0.12 | 0.44 | 2.27 |
| Lipocine Inc. (LPCN)vs › | $17.15M | 11.48 | 10.71 | 12.62 | 10.43 |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.13M | 6.03 | 7.38 | 5.62 | 4.97 |
Current Ratio
3.47
Quick Ratio
3.47
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 3.47 |
| 2026-03-31 | 4.61 |
| 2025-12-31 | 4.14 |
| 2025-09-30 | 2.97 |
| 2025-06-30 | 3.71 |
| 2025-03-31 | 10.26 |
| 2024-12-31 | 7.50 |
| 2024-09-30 | 9.07 |
| 2024-06-30 | 8.35 |
| 2024-03-31 | 10.70 |
| 2023-12-31 | 16.38 |
| 2023-09-30 | 18.72 |
| 2023-06-30 | 17.30 |
| 2023-03-31 | 23.77 |
| 2022-12-31 | 17.97 |
| 2022-09-30 | 29.76 |
| 2022-06-30 | 33.87 |
| 2022-03-31 | 32.52 |
| 2021-12-31 | 34.48 |
| 2021-09-30 | 32.95 |
| 2021-06-30 | 30.20 |
| 2021-03-31 | 33.35 |
| 2020-12-31 | 27.89 |
| 2020-09-30 | 51.73 |
| 2020-06-30 | 37.68 |
| 2020-03-31 | 40.07 |
| 2019-12-31 | 22.60 |
| 2019-09-30 | 15.00 |
| 2019-06-30 | 17.05 |
| 2019-03-31 | 12.77 |
| 2018-12-31 | 13.19 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
